Search
Alzheimer's Disease Paid Clinical Trials in Maryland
A listing of 16 Alzheimer's Disease clinical trials in Maryland actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 16 of 16
The state of Maryland currently has 16 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Baltimore, Bethesda, Rockville and Annapolis.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Healthy Volunteer Trials
Recruiting
Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Healthy
Featured Trial
Mild To Moderate Alzheimer's Disease Study
Recruiting
Join the effort to help research an investigational drug for Alzheimer's Disease. Those who qualify may receive:
o Compensation for time
o Reimbursement for study-related travel
o Study-related care from local doctors
o Study drug
o Compensation for time
o Reimbursement for study-related travel
o Study-related care from local doctors
o Study drug
Conditions:
Alzheimer Disease
Alzheimer's Disease
Alzheimer Dementia
Dementia Alzheimers
Dementia
Featured Trial
Cardiovascular Disease Trials
Recruiting
Cardiovascular Disease trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Cardiovascular Disease
Featured Trial
Overweight Trials
Recruiting
Overweight trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Overweight
Featured Trial
Low back pain Trials
Recruiting
Low back pain trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Low back pain
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Recruiting
The Anti-Aβ mAb CED Study is a prospective, longitudinal coverage with evidence development (CED) study using clinical data, patient assessments, and administrative claims data of the Medicare population, conducted in accordance to the National Coverage Determination (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD).
Gender:
All
Ages:
All
Trial Updated:
09/21/2023
Locations: Centers for Medicare and Medicaid Services, Baltimore, Maryland
Conditions: Mild Alzheimer's Disease, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Recruiting
This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve quality of life in those individuals.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
08/09/2023
Locations: Behavioral Pharmacology Research Unit, Baltimore, Maryland
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Recruiting
CORT-X will examine if mitigation of stress-mediated pathogenesis of Alzheimer's disease (AD) is a feasible target for intervention in individuals at risk for this disease. This single-site (Baltimore, Maryland) phase II clinical trial is a 2-week, randomized, placebo-controlled crossover study of the effects of the selective glucocorticoid receptor antagonist, CORT108297, on cognitive test performance in 26 individuals with mild cognitive impairment (MCI) due to AD and in 26 cognitively normal... Read More
Gender:
All
Ages:
55 years and above
Trial Updated:
07/06/2023
Locations: Johns Hopkins School of Medicine, Baltimore, Maryland
Conditions: Mild Cognitive Impairment, Alzheimer Disease, Memory Impairment
MEMORI Corps: Activity-based Companion Care for Dementia
Recruiting
This is a single blind, intention-to-treat, randomized controlled trial design to evaluate the feasibility and efficacy of a 12-week, evidence-based, individualized MEMORI Corps program delivered by trained older volunteers (n=80) to community-living PWD/CG dyads (n=240). Eligible PWD/CG dyads will be randomized to receive 12-weeks intervention group (n=120), or 12-week augmented waitlist control group (n=120) followed by 12-weeks of intervention. Eligible volunteers will be randomized to 12 mon... Read More
Gender:
All
Ages:
Between 18 years and 115 years
Trial Updated:
06/23/2023
Locations: Johns Hopkins University, Baltimore, Maryland
Conditions: Alzheimer Disease, Dementia
13 - 16 of 16